Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Baker

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|March 19, 1981
More on reliability of death certificatesF F Holms, L H Baker, E M Hearne, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.
Cancer|August 1, 1978
Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survivalM H Amer, M Al-Sarraf, L H Baker, et al.
Journal of General Internal Medicine|March 1, 1996
Effects of a physician communication intervention on patient care outcomesS K Joos, D H Hickam, G H Gordon, et al.
Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.
Cancer Treatment Reports|June 1, 1984
Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group studyS A Taylor, D D Von Hoff, L H Baker, et al.
Cancer|November 1, 1977
Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group reportC Leite, J W Goodwin, J G Sinkovics, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1976
Use of clindamycin in patients with liver diseaseD R Hinthorn, L H Baker, D A Romig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Clinical pharmacokinetics of high-dose mitomycin CR B Schilcher, J D Young, V Ratanatharathorn, et al.
American Journal of Clinical Oncology|February 1, 1983
Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group StudyB L Zidar, R S Benjamin, J Frank, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|March 19, 1981
More on reliability of death certificatesF F Holms, L H Baker, E M Hearne, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 daysP L Lomen, L H Baker, G L Neil, et al.
Cancer|August 1, 1978
Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survivalM H Amer, M Al-Sarraf, L H Baker, et al.
Journal of General Internal Medicine|March 1, 1996
Effects of a physician communication intervention on patient care outcomesS K Joos, D H Hickam, G H Gordon, et al.
Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.
Cancer Treatment Reports|June 1, 1984
Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group studyS A Taylor, D D Von Hoff, L H Baker, et al.
Cancer|November 1, 1977
Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group reportC Leite, J W Goodwin, J G Sinkovics, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1976
Use of clindamycin in patients with liver diseaseD R Hinthorn, L H Baker, D A Romig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Clinical pharmacokinetics of high-dose mitomycin CR B Schilcher, J D Young, V Ratanatharathorn, et al.
American Journal of Clinical Oncology|February 1, 1983
Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group StudyB L Zidar, R S Benjamin, J Frank, et al.
Pageof 17